<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>Neurocrine Biosciences RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehen</description><link>http://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><image><url>http://images.finanzen.net/images/finanzen_net_neu.gif</url><title>Finanzen.net</title><link>http://www.finanzen.net</link></image><item><title>Lerach Coughlin Stoia Geller Rudman &amp; Robbins LLP Files Class Action Suit Against Neurocrine Biosciences, Inc.</title><link>http://www.finanzen.net/nachricht/aktien/Lerach-Coughlin-Stoia-Geller-Rudman-Robbins-LLP-Files-Class-Action-Suit-Against-Neurocrine-Biosciences-Inc-183066</link><description>Lerach Coughlin Stoia Geller Rudman &amp; Robbins LLP ("Lerach 
      Coughlin”) (http://www.lerachlaw.com/cases/neurocrine/) 
      today announced that a class action has been commenced on behalf of an 
      institutional investor in the United States  ...</description><guid isPermaLink="true">http://www.finanzen.net/nachricht/aktien/Lerach-Coughlin-Stoia-Geller-Rudman-Robbins-LLP-Files-Class-Action-Suit-Against-Neurocrine-Biosciences-Inc-183066</guid></item></channel></rss>

